轴性脊柱关节炎从症状发作到诊断的衔接:分层筛查研究
该前瞻性研究纳入405例初级保健腰痛患者,采用分层筛查流程:初级标准化临床筛查后,对腰痛>3个月且症状发作年龄<50岁者转诊至风湿科培训的物理治疗师进行二级筛查,并按炎症特征分为轴性SpA低、中、高风险或无风险。二级筛查灵敏度68%、特异度90%、阳性预测值80%、阴性预测值84%;最终15.6%诊断为轴性SpA,非放射学轴性SpA中位腰痛病程2年,强直性脊柱炎7年。
要点
- 分层筛查中二级筛查灵敏度68%、特异度90%、阳性预测值80%、阴性预测值84%。
- 初级至二级筛查中位等待时间15天,最终15.6%患者诊断为轴性SpA。
- 非放射学轴性SpA中位腰痛病程2年,强直性脊柱炎7年。
核心结论
- 分层跨专业筛查流程可促进持续性腰痛患者中轴性SpA的快速诊断,且具有较高精准度和准确性。
研究设计与样本
- 前瞻性研究,405例在初级保健腰痛门诊就诊的成人接受初级标准化临床筛查。
- 腰痛>3个月且症状发作年龄<50岁者转诊至接受高级风湿科培训的物理治疗师进行二级筛查。
- 二级筛查将具有炎症特征的患者分为轴性SpA低、中、高风险或无风险,以轴性SpA专家风湿科医生的评估为参照标准。
主要发现
- 研究队列平均年龄36.9±9.9岁,女性占55%,HLA-B27阳性率14.4%。
- 初级筛查至二级筛查的中位等待时间为15天。
- 风湿科医生评估无风险或低风险占64.9%,中风险或高风险占35.1%。
- 二级筛查灵敏度68%、特异度90%、阳性预测值80%、阴性预测值84%。
- 最终15.6%患者诊断为轴性SpA;非放射学轴性SpA中位腰痛病程2年,强直性脊柱炎7年。
关键数值与推荐
- 初级筛查纳入标准:腰痛>3个月且症状发作年龄<50岁。
- 二级筛查风险分层:低、中、高风险或无风险,以风湿科专家评估为参照。
- 二级筛查灵敏度68%、特异度90%、阳性预测值80%、阴性预测值84%。
临床怎么用
- 在初级保健中可对持续性腰痛且症状发作年龄<50岁者采用分层筛查流程快速转诊。
- 二级筛查由接受风湿科培训的物理治疗师进行风险分层,有助于提高诊断精准度。
- 该流程可缩短轴性SpA从症状发作到诊断的时间,尤其对非放射学轴性SpA。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate a stratified screening process for the early identification of axial spondyloarthritis (SpA) with consideration of the following: 1) wait times from primary care to rheumatology screen, 2) incremental precision and accuracy from primary care to rheumatology screening, and 3) diagnostic delay. METHODS: Adults with low back pain attending primary care at low back pain clinics prospectively underwent a primary standardized clinical screening. Patients with low back pain of >3 months who experienced symptom onset at age <50 years were referred for a comprehensive secondary screening by a physical therapist with advanced rheumatology training. At secondary screening, patients with features of inflammation were classified as being at a low, medium, or high risk for axial SpA versus no risk for axial SpA. Precision and accuracy of this screening strata were measured against a rheumatologist with expertise in axial SpA. RESULTS: Overall, 405 patients underwent primary and secondary screening in the present study. The study cohort had a mean ± SD age of 36.9 ± 9.9 years, and 55% were women. HLA-B27 was present in 14.4% of patients. Median wait time from primary screening to secondary screening was 15 days. Axial SpA risk assignment by rheumatologist was 64.9% for no risk or low risk for axial SpA and 35.1% for medium risk or high risk for axial SpA. The best combination of sensitivity (68%), specificity (90%), positive predictive values (80%), and negative predictive values (84%) was evident in the secondary screening. In this cohort, 15.6% of patients received a final diagnosis of axial SpA. Median low back pain duration from symptom onset to diagnosis was 2 years for nonradiographic axial SpA and 7 years for ankylosing spondylitis. CONCLUSION: A stratified interprofessional screening process can facilitate rapid diagnosis of persistent low back pain with high precision and accuracy in patients who have axial SpA.
引用
- Passalent L, Sundararajan K, Perruccio AV, et al. Bridging the Gap Between Symptom Onset and Diagnosis in Axial Spondyloarthritis. Arthritis Care Res (Hoboken). 2022. PMID: 34268914. doi:10.1002/acr.24751
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。